Daiichi Sankyo Company, Limited, a Japanese pharmaceutical company, has announced the expansion of Take a New Challenge for Drug Discovery, or TaNeDS, collaborative drug discovery program in Europe. The TaNeDS program was launched in Japan in 2011 ... Individual.com, 1 week ago
Daiichi Sankyo Posts Data from Subgroup Analysis of ENGAGE AF-TIMI 48 - Individual.com, 1 week ago
Daiichi Sankyo initiates Phase III rheumatoid arthritis trial in Japan - Individual.com, 1 week ago
More from: Asia Net, PharmaBiz...and 67 other sources
3 images for "daiichi sankyo company"
Daiichi Sankyo Espha Co., Ltd., a generic drug subsidiary of Daiichi Sankyo Company, Limited, has received a manufacturing and marketing license in Japan for Levofloxacin Tablets 250mg DSEP, 500mg DSEP and Granules 10% DSEP. Levofloxacin is an oral ...Individual.com, 1 week ago Daiichi Sankyo Espha gets Japanese approval for manufacturing and marketing levofloxacin tablets PharmaBiz, 2 weeks ago Daiichi-Sankyo reports higher Q1 profit, provides annual outlook Individual.com, 3 weeks ago
For Immediate Release 2014.09.02 Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of CANAGLU® Tablets 100mg A SGLT2 inhibitor for Type2 Diabetes Mellitus OSAKA and TOKYO, Japan (September 2, 2014)-Mitsubishi ...4 Traders, 2 weeks ago Mitsubishi Tanabe Pharma, Daiichi Sankyo to launch Canaglu tabs in Japan for type 2 diabetes mellitus PharmaBiz, 2 weeks ago Launch of CANAGLU® Tablets 100mg European Pharmaceutical Review, 2 weeks ago
Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo in a deal that would create the world's fifth largest generic drugmaker. Photo: Bloomberg New Delhi: India's antitrust regulator has ordered a ...Livemint.com, 2 weeks ago Sun, Ranbaxy hire Mckinsey for merger assistance Rediff.com, 2 months ago Indian bourses' nod for Sun Pharma-Ranbaxy deal Rediff.com, 1 month ago Sun Pharma-Ranbaxy deal gets BSE, NSE clearance Deccan Herald, 1 month ago
TOKYO/JAKARTA -- Pharmaceutical companies have largely been unwilling to develop vaccines and treatment for dengue fever, citing small demand due to the disease primarily occurring in emerging nations. But as the disease spreads, with the current ...Nikkei Asian Review, 19 hours ago
Research and Markets (http://www.researchandmarkets.com/research/xr5nbq/atrial) has announced the addition of the "Atrial Fibrillation - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the ...Individual.com, 1 week ago Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles Individual.com, 1 week ago Research and Markets: Tetanus Therapeutics Pipeline Review, H2 2014 - 15 Companies with 29 Drug Profiles TMC Net, 1 week ago RESEARCH AND MARKETS : Tetanus Therapeutics Pipeline Review, H2 2014 - 15 Companies with 29 Drug Profiles 4 Traders, 1 week ago
Affimed Therapeutics B.V . (AFMD), based in Heidelberg, Germany is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Two companies are scheduled for the week of September 8, ...4 Traders, 20 hours ago IPO Report: Affimed Therapeutics B.V. (AFMD) Equities.com, 5 days ago IPO Preview: Affimed Therapeutics Seeking Alpha, 5 days ago
Companies love the idea of India, with its huge untapped market and its vast, cheap workforce. But they know there are potential problems; Japanese suitors have stumbled more than once before. Photo: Bloomberg Tokyo: Even as the friendship between ...Livemint.com, 6 days ago Japan Inc cautious on India despite premiers' love-in Yahoo! Malaysia, 1 week ago Japan Inc wary of doing business in India Malay Mail, 1 week ago Japan Inc. cautious on India despite premiers love-in Korea Herald, 6 days ago
Munich/Amsterdam, 15 September 2014. It is with great pleasure that today, LSP the specialist European healthcare investment firm announces that its portfolio company Affimed was successfully listed on the NASDAQ stock exchange on Friday September ...Tornado Insider, 1 day ago
ets are expected to open flat tracking SGX Nifty and Asian markets. U.S. stocks rose led by surge in the technology shares due to rally in Apple Inc. European stocks were on sidelines due to lingering questions on whether the ECB stimulus would ...Stock Markets Review, 6 days ago Indian share markets open firm Equitymaster.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!